These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15450303)

  • 1. Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma.
    Li G; Yang T; Li L; Yan J; Zeng Y; Yu J; Zhang Y
    Colloids Surf B Biointerfaces; 2004 Aug; 37(1-2):15-9. PubMed ID: 15450303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
    Zhan J; Tang XD
    Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
    Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP
    J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder.
    Shariat SF; Matsumoto K; Kim J; Ayala GE; Zhou JH; Jian W; Benedict WF; Lerner S
    J Urol; 2003 Sep; 170(3):985-9. PubMed ID: 12913755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of cyclooxygenase in bladder transitional cell carcinoma].
    Wang KJ; Li H; Wei Q; Yang YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on cyclooxygenase-2 protein expression and vasculature during experimental rat lung carcinogenesis].
    Li HG; Yu LY; Liu MQ; Chen HL; Zhang YX; Liu X; Tang ZJ; Xia D; Zou ZY
    Ai Zheng; 2002 Jun; 21(6):605-9. PubMed ID: 12452059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
    Mohammed SI; Bennett PF; Craig BA; Glickman NW; Mutsaers AJ; Snyder PW; Widmer WR; DeGortari AE; Bonney PL; Knapp DW
    Cancer Res; 2002 Jan; 62(2):356-8. PubMed ID: 11809678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial cell cyclooxygenase-2 expression is associated with increased angiogenesis in human sporadic colorectal adenomas.
    Chapple KS; Scott N; Guillou PJ; Coletta PL; Hull MA
    J Pathol; 2002 Dec; 198(4):435-41. PubMed ID: 12434412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
    Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
    Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients.
    Masunaga R; Kohno H; Dhar DK; Ohno S; Shibakita M; Kinugasa S; Yoshimura H; Tachibana M; Kubota H; Nagasue N
    Clin Cancer Res; 2000 Oct; 6(10):4064-8. PubMed ID: 11051257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between angiogenesis and cyclooxygenase-2 expression in prostate cancer.
    Mukherjee R; Edwards J; Underwood MA; Bartlett JM
    BJU Int; 2005 Jul; 96(1):62-6. PubMed ID: 15963122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up.
    Bartoletti R; Cai T; Nesi G; Sardi I; Rizzo M
    Oncol Rep; 2005 Jul; 14(1):251-5. PubMed ID: 15944797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer.
    Koga T; Shibahara K; Kabashima A; Sumiyoshi Y; Kimura Y; Takahashi I; Kakeji Y; Maehara Y
    Hepatogastroenterology; 2004; 51(60):1626-30. PubMed ID: 15532792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer.
    Jaeger TM; Weidner N; Chew K; Moore DH; Kerschmann RL; Waldman FM; Carroll PR
    J Urol; 1995 Jul; 154(1):69-71. PubMed ID: 7539869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.
    Ristimäki A; Nieminen O; Saukkonen K; Hotakainen K; Nordling S; Haglund C
    Am J Pathol; 2001 Mar; 158(3):849-53. PubMed ID: 11238034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression.
    Wendum D; Boëlle PY; Rigau V; Sebbagh N; Olschwang S; Mourra N; Parc R; Trugnan G; Masliah J; Fléjou JF
    Virchows Arch; 2003 Feb; 442(2):111-7. PubMed ID: 12596060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2 and EP4 receptor in transitional cell carcinoma of the upper urinary tract.
    Miyata Y; Kanda S; Nomata K; Eguchi J; Kanetake H
    J Urol; 2005 Jan; 173(1):56-60. PubMed ID: 15592025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.